Cleveland BioLabs
$2.699876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$2.69
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.41 (+17.98%) As of 1:54 PM EST today
+$0.41 (+17.98%) Today
Why Robinhood?
You can buy or sell CBLI and other stocks, options, ETFs, and crypto commission-free!
About CBLI
Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. Read More It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY.
Employees
16
Headquarters
Buffalo, New York
Founded
2003
Market Cap
22.48M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
542.54K
High Today
$2.98
Low Today
$2.22
Open Price
$2.28
Volume
1.75M
52 Week High
$4.90
52 Week Low
$0.50
Collections
CBLI Earnings
-$0.10
-$0.07
-$0.03
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
— per share
Actual
Expected Mar 5, After Hours
People Also Bought
NIO
130,296
$4.41
+0.23%Ford
388,288
$7.23
-0.07%Chesapeake Energy
139,704
$0.3251
-26.76%Aurora Cannabis
673,523
$1.50
-0.66%Oragenics
47,920
$0.556
-1.45%Geron
31,481
$1.16
+0.85%Denbury
35,891
$0.8024
-4.73%GE
330,163
$10.97
-3.09%India Globalization Capital
57,709
$0.4948
-7.81%Washington Prime Group
23,656
$2.27
-5.81%Kitov Pharmaceuticals
1,957
$0.66
+0.87%Actinium Pharmaceuticals
10,134